Company creates 25 market-ready GLP-1 complementary food, supplement concepts.

Positives were identified across the spectrum of "ultra-processed" grains tracked in the study. 

Nestle appears more focused on reducing rather than increasing its exposure to food. 

These rates are 35% or higher in 23 states.

Companies are developing more products that align with the trend.
 

Proprietary research sheds light on opportunities for food manufacturers amid the rise of GLP-1.

Appetite-suppressing drug threatens to impact flour consumption.

Vital Pursuit will feature bowls, sandwich melts and pizza.
 

Agitation over the potential impact of the medications has been exacerbated by surveys showing tens of millions of respondents expressing an interest in a drug that could help them lose weight safely. 

ADM identifies the innovations and ideas needed to support category growth.